- Rating
- 1
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 1
Read review
Paper summary
To address the problem that structure-based bimolecular design typically optimizes candidates against a single static target conformation, this paper proposed FLEXEVO, which is an evolutionary optimization algorithm to adapts conformation generated by design models without fine-tuning base model or providing conformation ensembles. The model formalizes cross-conformation design as a geometric constrained bi-objective optimization problem and requires no training, covering small molecules, peptides, antibodies, mRNA, etc., reducing performance degradation significantly from 47.8% to 4.4% with low computational cost.
Critical strengths
- FLEXEVO used simple local geometric perturbation instead of expensive conformations generated by MD simulations or ensemble-predicting models as stress tests for unknown conformations, serving as a plug-and-play inference-time plugin that can be used in any models with low computational cost.
- The experiment design covered 9 drug molecules classes ranging from small molecules to large mRNAs, convincingly demonstrated the extrapolation capacity of the method.
Critical weaknesses
- The method is not positioned as a "de novo design" framework like RFDiffusion models. All experiments are conducted under graph preserving mode, which allows no atom addtions, deletions or changes of chemical bonds. So it only serves as a dihedral fine-tuning algorithm.
- The algorithm relies on local perturbations and lacks theoretical coverage guarantees, but achieves significant improvements under drastic changes even in propeptide-associated. The mechanistic explanation is lacking.
Questions for authors
- In experiment, baselines only used first candidate, while FLEXEVO selects from 64. Does the gain of performance comes from candidate ranking or geometric editing? Please compare FLEXEVO with re-rank-only and a standard local relaxation baseline under same computational budgets.
- How do authors explain the highly similar data across different modalities? For example, in tab.6 and tab.10, all 18 DockQ means for proteins and long chain mRNA matches within 1e-3 error, in fig.25, subfigure (a-c small molecules) are exactly the same as subfigure (d-f macrocycles).